PRP19 Enhances Esophageal Squamous Cell Carcinoma Progression by Reprogramming SREBF1-Dependent Fatty Acid Metabolism

Overview

Journal Cancer Res

Specialty Oncology

Date 2023 Feb 1

PMID 36723974

Authors

Guang-Cong Zhang

Xiang-Nan Yu

Hong-Ying Guo

Jia-Lei Sun

Zhi-Yong Liu

Ji-Min Zhu

Tao-Tao Liu

Ling Dong

Xi-Zhong Shen

Jie Yin

Affiliations

Soon will be listed here.

Abstract

Significance: Upregulation of pre-mRNA processing factor 19 (PRP19) contributes to esophageal squamous cell carcinoma progression by reprogramming SREBF1-dependent fatty acid metabolism, identifying PRP19 as a potential prognostic biomarker and therapeutic target.

Citing Articles

SOX11 exacerbates ferroptosis to reduce lenvatinib resistance in liver cancer cells by promoting ubiquitination degradation of SREBF1 through upregulating UBE3A.

Chen Z, Ou L, Ma L Mol Cell Biochem. 2025; .

PMID: 40025300 DOI: 10.1007/s11010-025-05218-x.

Metabolic reprogramming and immunological changes in the microenvironment of esophageal cancer: future directions and prospects.

Guo Z, Ma J, Zhang J, Yan L, Zhou Y, Mao X Front Immunol. 2025; 16:1524801.

PMID: 39925801 PMC: 11802498. DOI: 10.3389/fimmu.2025.1524801.

Sterol regulatory element binding transcription factor 1 is an important prognostic factor for colon adenocarcinoma and closely related to immune infiltration.

Jin L, Lin Z, Jin A Cytojournal. 2025; 21:67.

PMID: 39917010 PMC: 11801665. DOI: 10.25259/Cytojournal_43_2024.

Copy number amplification of FLAD1 promotes the progression of triple-negative breast cancer through lipid metabolism.

Song X, Yu T, Ou-Yang Y, Ding J, Jiang Y, Shao Z Nat Commun. 2025; 16(1):1241.

PMID: 39890808 PMC: 11785949. DOI: 10.1038/s41467-025-56458-w.

Targeting lipid metabolism: novel insights and therapeutic advances in pancreatic cancer treatment.

Zhang Y, Yang Z, Liu Y, Pei J, Li R, Yang Y Lipids Health Dis. 2025; 24(1):12.

PMID: 39806478 PMC: 11727729. DOI: 10.1186/s12944-024-02426-0.